Open access
Jul 2026
Immunogenicity and safety of BNT162b2 vaccine in patients with juvenile immune mediated inflammatory disease.
The BNT162b2 vaccine was safe and immunogenic in adolescents with IMIDs, including those with high immunosuppression and comorbidities, showing similar responses to adults, which support vaccination in this vulnerable population and contribute to evidence-based recommendations.
C. Gadelha, Maria Teresa Terreri, A. Burian et al.
· Pediatric Research · 0 citations